BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Evolent Health Announces Second Quarter 2019 Results

  Evolent Health, Inc. (NYSE: EVH), a company providing an integrated value-based care platform to the nation’s leading physician and payer organizations, today announced financial results for the quarter ended June 30, 2019.

  August 6, 2019

   · 

  42 min read
• Business

  CytoSorbents Reports Record Second Quarter 2019 Financial Results

  CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader using its CytoSorb® blood purification technology to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, reports financial and operational results for the quarter ending June 30, 2019

  August 6, 2019

   · 

  21 min read
• Business

  Arcus Biosciences Announces Second Quarter 2019 Financial Results and Recent Corporate Updates

  Received IND clearance to initiate a Phase 1/1b trial for AB680, the first small-molecule CD73 inhibitor to enter the clinic, in first-line metastatic pancreatic cancer

  August 6, 2019

   · 

  11 min read
• Business

  Community Healthcare Trust Announces Results for the Three Months Ended June 30, 2019

  Funds from operations and adjusted funds from operations (“AFFO”) for the three months ended June 30, 2019 totaled $0.40 and $0.42, respectively, per diluted common share.

  August 6, 2019

   · 

  11 min read
• Business

  RMS Medical Products Announces 2019 Second Quarter Financial Results

  Conference Call Scheduled for August 7 at 9:00 am ET

  August 6, 2019

   · 

  12 min read
• Biotech Beach

  Beckman Coulter MicroScan Wins IMV ServiceTrak™ Best System Performance for the Second Year in a Row

  The Best System Performance award was presented to Beckman Coulter today at the 71st AACC Annual Scientific Meeting & Clinical Lab Expo in Anaheim, Calif.

  August 6, 2019

   · 

  4 min read
• Policy

  Dupixent® (dupilumab) Approved by European Commission for Adolescents with Moderate-to-Severe Atopic Dermatitis

  Regeneron Pharmaceuticals, Inc. and Sanofi announced that the European Commission extended marketing authorization for Dupixent® in the European Union to include adolescents 12 to 17 years of age with moderate-to-severe atopic dermatitis who are candidates for systemic therapy.

  August 6, 2019

   · 

  19 min read
• Policy

  Dupixent® (dupilumab) Showed Positive Topline Results in Phase 3 Trial of Children Aged 6 to 11 Years with Severe Atopic Dermatitis

  Regeneron Pharmaceuticals, Inc. and Sanofi announced that a pivotal Phase 3 trial evaluating Dupixent® to treat severe atopic dermatitis in children aged 6 to 11 years met its primary and secondary endpoints.

  August 6, 2019

   · 

  18 min read
• Business

  ‘MYM International Brands Inc.’ Incorporated to Focus on Burgeoning Global Demand for CBD-Rich Consumer Products

  The passing of the Farm Bill in 2018 allowed for the cultivation of CBD-rich hemp in the United States.

  August 6, 2019

   · 

  4 min read
• Business

  Global Medical Laser Company Transitions As PBM Laser Therapy Market Grows

  Leading Provider of Class IV Lasers Becomes Summus Medical Laser™; Offers Advanced Technology for Practice Management

  August 6, 2019

   · 

  2 min read